Advertisement
BIOX vs UAN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIOX is a Hold and UAN is a StrongBuy.
BIOX's RSI Indicator ascends from oversold territory
The RSI Indicator for BIOX moved out of oversold territory on November 02, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 37 similar instances when the indicator left oversold territory. In 30 of the 37 cases the stock moved higher. This puts the odds of a move higher at 81%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 39 of 62 cases where BIOX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 63%.
The Moving Average Convergence Divergence (MACD) for BIOX just turned positive on November 04, 2026. Looking at past instances where BIOX's MACD turned positive, the stock continued to rise in 29 of 44 cases over the following month. The odds of a continued upward trend are 66%.
Following a +11.72% 3-day Advance, the price is estimated to grow further. Considering data from situations where BIOX advanced for three days, in 179 of 237 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
BIOX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BIOX as a result. In 89 of 103 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BIOX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The Aroon Indicator for BIOX entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.220) is normal, around the industry mean (-0.492). P/E Ratio (-0.263) is within average values for comparable stocks, (8.794). Projected Growth (PEG Ratio) (1.236) is also within normal values, averaging (0.867). Dividend Yield (0.000) settles around the average of (0.126) among similar stocks. BIOX's P/S Ratio (0.103) is slightly lower than the industry average of (1.476).
The Tickeron Price Growth Rating for this company is 90 (best 1 - 100 worst), indicating slightly worse than average price growth. BIOX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BIOX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
UAN's RSI Oscillator recovers from oversold territory
The RSI Indicator for UAN moved out of oversold territory on November 10, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 23 similar instances when the indicator left oversold territory. In 19 of the 23 cases the stock moved higher. This puts the odds of a move higher at 83%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.39% 3-day Advance, the price is estimated to grow further. Considering data from situations where UAN advanced for three days, in 237 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
UAN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UAN as a result. In 51 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 60%.
The Moving Average Convergence Divergence Histogram (MACD) for UAN turned negative on October 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 29 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 66%.
UAN moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UAN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.335) is normal, around the industry mean (-0.492). P/E Ratio (7.222) is within average values for comparable stocks, (8.794). Projected Growth (PEG Ratio) (0.450) is also within normal values, averaging (0.867). Dividend Yield (0.222) settles around the average of (0.126) among similar stocks. P/S Ratio (2.073) is also within normal values, averaging (1.476).
The Tickeron SMR rating for this company is 21 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 22 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. UAN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 59 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
BIOX | UAN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 10 | 78 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 55 Fair valued | 16 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 22 | |
SMR RATING 1..100 | 95 | 21 | |
PRICE GROWTH RATING 1..100 | 90 | 58 | |
P/E GROWTH RATING 1..100 | 14 | 59 | |
SEASONALITY SCORE 1..100 | 45 | 65 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
UAN's Valuation (16) in the Chemicals Agricultural industry is somewhat better than the same rating for BIOX (55) in the Financial Conglomerates industry. This means that UAN’s stock grew somewhat faster than BIOX’s over the last 12 months.
UAN's Profit vs Risk Rating (22) in the Chemicals Agricultural industry is significantly better than the same rating for BIOX (100) in the Financial Conglomerates industry. This means that UAN’s stock grew significantly faster than BIOX’s over the last 12 months.
UAN's SMR Rating (21) in the Chemicals Agricultural industry is significantly better than the same rating for BIOX (95) in the Financial Conglomerates industry. This means that UAN’s stock grew significantly faster than BIOX’s over the last 12 months.
UAN's Price Growth Rating (58) in the Chemicals Agricultural industry is in the same range as BIOX (90) in the Financial Conglomerates industry. This means that UAN’s stock grew similarly to BIOX’s over the last 12 months.
BIOX's P/E Growth Rating (14) in the Financial Conglomerates industry is somewhat better than the same rating for UAN (59) in the Chemicals Agricultural industry. This means that BIOX’s stock grew somewhat faster than UAN’s over the last 12 months.
| BIOX | UAN | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 81% | 2 days ago 83% |
| Stochastic ODDS (%) | 2 days ago 63% | 2 days ago 71% |
| Momentum ODDS (%) | 2 days ago 86% | 2 days ago 60% |
| MACD ODDS (%) | 2 days ago 66% | 2 days ago 66% |
| TrendWeek ODDS (%) | 2 days ago 87% | 2 days ago 69% |
| TrendMonth ODDS (%) | 2 days ago 87% | 2 days ago 59% |
| Advances ODDS (%) | 4 days ago 76% | 2 days ago 73% |
| Declines ODDS (%) | 14 days ago 87% | 8 days ago 58% |
| BollingerBands ODDS (%) | 2 days ago 71% | 2 days ago 81% |
| Aroon ODDS (%) | 2 days ago 90% | N/A |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BIOX’s FA Score shows that 1 FA rating(s) are green while UAN’s FA Score has 3 green FA rating(s).
- BIOX’s FA Score: 1 green, 4 red.
- UAN’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BIOX’s TA Score shows that 5 TA indicator(s) are bullish while UAN’s TA Score has 4 bullish TA indicator(s).
- BIOX’s TA Score: 5 bullish, 3 bearish.
- UAN’s TA Score: 4 bullish, 4 bearish.
Price Growth
BIOX (@Chemicals: Agricultural) experienced а -8.17% price change this week, while UAN (@Chemicals: Agricultural) price change was +0.80% for the same time period.
The average weekly price growth across all stocks in the @Chemicals: Agricultural industry was -3.54%. For the same industry, the average monthly price growth was -10.79%, and the average quarterly price growth was -20.52%.
Industries' Descriptions
@Chemicals: Agricultural (-3.54% weekly)The agricultural chemicals sector includes companies that produce chemical products for the agricultural industry applications like crop protection, animal health, biotechnology and pharmaceutical-related products. Some of the largest agricultural chemicals producers include Nutrien Ltd., Corteva Inc., and FMC Corporation.
Advertisement
BIOX and
Correlation & Price change
A.I.dvisor tells us that BIOX and UAN have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIOX and UAN's prices will move in lockstep.
| Ticker / NAME | Correlation To BIOX | 1D Price Change % | ||
|---|---|---|---|---|
| BIOX | 100% | +9.20% | ||
| UAN - BIOX | 21% Poorly correlated | +0.42% | ||
| SEED - BIOX | 20% Poorly correlated | -2.96% | ||
| IPI - BIOX | 20% Poorly correlated | -1.29% | ||
| FMC - BIOX | 20% Poorly correlated | +0.18% | ||
| SMG - BIOX | 20% Poorly correlated | -0.14% | ||
More | ||||
UAN and
Correlation & Price change
A.I.dvisor indicates that over the last year, UAN has been loosely correlated with CF. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if UAN jumps, then CF could also see price increases.
| Ticker / NAME | Correlation To UAN | 1D Price Change % | ||
|---|---|---|---|---|
| UAN | 100% | +0.42% | ||
| CF - UAN | 52% Loosely correlated | +0.72% | ||
| IPI - UAN | 37% Loosely correlated | -1.29% | ||
| NTR - UAN | 31% Poorly correlated | -0.72% | ||
| RKDA - UAN | 23% Poorly correlated | +43.82% | ||
| CTVA - UAN | 23% Poorly correlated | -0.25% | ||
More | ||||